Clinical Trial Update: Investigating Eye-Movement Biomarkers of Disease Severity and Cognition in Multiple Sclerosis

View source ↗

Summary

A completed clinical trial evaluated whether eye-movement measurements reflect disease severity and cognitive function in people with multiple sclerosis. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Innodem Neurosciences | Conditions: Multiple Sclerosis | Status: COMPLETED